Treatment of Anemia in Transfusion-Dependent and Non-Transfusion-Dependent Lower-Risk MDS: Current and Emerging Strategies

Myelodysplastic syndromes (MDS) are a heterogeneous group of bone marrow disorders with a highly diverse clinical course. For lower-risk MDS patients, therapeutic objectives aim to correct chronic anemia and improve/maintain health-related quality of life (HRQoL). However, disease burden is often in...

Descripción completa

Detalles Bibliográficos
Autores principales: Germing, Ulrich, Oliva, Ester N., Hiwase, Devendra, Almeida, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924547/
https://www.ncbi.nlm.nih.gov/pubmed/31976486
http://dx.doi.org/10.1097/HS9.0000000000000314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924547/
https://www.ncbi.nlm.nih.gov/pubmed/31976486
http://dx.doi.org/10.1097/HS9.0000000000000314

Ejemplares similares